![](/img/cover-not-exists.png)
5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT)
Gullo, G., Zuradelli, M., Kelleher, F., Sclafani, F., Donovan, N. O', Lyons, T., Masci, G., Santoro, A., Crown, J.Volume:
47
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(11)71442-3
Date:
September, 2011
File:
PDF, 57 KB
english, 2011